Advanced search
Publication Cover
Immunological Medicine Volume 43, 2020 - Issue 1
Submit an article Journal homepage
1,487
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Yasuhiro KatsumataDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Correspondence[email protected]
View further author information
,
Yuko OkamotoDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information
,
Takahito MoriyamaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information
,
Rina MoriyamaDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information
,
Manabu KawamotoDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information
,
Masanori HanaokaDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information
,
Keiko UchidaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information
,
Kosaku NittaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information
&
Masayoshi HarigaiDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information
 show all
Pages 47-56 | Received 27 Nov 2019, Accepted 20 Dec 2019, Published online: 07 Jan 2020

References

  • Beck LH, Jr, Salant DJ. Membranous nephropathy: from models to man. J Clin Invest. 2014;124(6):2307–2314.
  • Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. Lancet. 2015;385(9981):1983–1992.
  • Beck LH, Jr., Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.
  • Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. JASN. 2012;23(10):1735–1743.
  • Kanigicherla D, Gummadova J, McKenzie EA, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013;83(5):940–948.
  • Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. JASN. 2014;25(6):1357–1366.
  • Ruggenenti P, Debiec H, Ruggiero B, et al. Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. JASN. 2015;26(10):2545–2558.
  • Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-A-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26(8):2526–2532.
  • Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, et al. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol. 2014;142(1):29–34.
  • Hofstra JM, Wetzels JF. Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues. JASN. 2014;25(6):1137–1139.
  • Qin W, Beck LH, Jr., Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. JASN. 2011;22(6):1137–1143.
  • Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–1277.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725–1725.
  • Weening JJ, D'Agati VD, Schwartz MM, et al. ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–530.
  • Chapter 7: Idiopathic membranous nephropathy. Kidney Int Suppl. 2012;2(2):186–197.
  • Timmermans SA, Abdul Hamid MA, Cohen Tervaert JW, et al. on behalf of the Limburg Renal Registry. Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy. Am J Nephrol. 2015;42(1):70–77.
  • van de Logt AE, Hofstra JM, Wetzels JF. Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up. Kidney Int. 2015;87(6):1263–1264.
  • Ramachandran R, Kumar V, Nada R, et al. Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int. 2015;88(5):1198–1199.
  • Akiyama S, Akiyama M, Imai E, et al. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol. 2015;19(4):653–660.
  • Hayashi N, Akiyama S, Okuyama H, et al. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese. Clin Exp Nephrol. 2015;19(5):797–803.
  • Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011;364(7):689–690.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.